Drug Database
Back to search

Switzerland· 62687002

Alacare

A aminolevulinic acid product containing aminolaevulinatis hydrochloridum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC L01XD04

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAlacareATCL01XD04REGISTER NO.62687002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aminolaevulinatis hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aminolevulinic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC L01XD04 (aminolevulinic acid), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search aminolevulinic acid products by name

Aminolevulinic acid · ATC L01XD04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
aminolaevulinatis hydrochloridum
Manufacturer
—
Country
Switzerland (CH)
ATC code
L01XD04
ATC class
Aminolevulinic acid
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680626870022
    8 Stk
    CHF 246.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

121 interactions on record for aminolevulinic acid.

Graded by severity as the source publishes them — 120 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aminolevulinic acid against other medicinesHow interaction checks work

Aminolevulinic acid · interactions on record

121 records

  • 120 severe
  • 1 moderate

Most severe, free to view

  • MinocyclineA01AB23severe
  • SulfasalazineA07EC01severe
  • GlibenclamideA10BB01severe
  • ChlorpropamideA10BB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aminolevulinic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aminolevulinic acid products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Alacare
  • Belgium · Effala
  • Czechia · Alacare
  • Germany · Alacare
  • Denmark · Alacare
  • Finland · Alacare
  • France · Effala
  • United Kingdom (Northern Ireland) · Alacare
  • Ireland · Alacare
  • Iceland · Ameluz, Gliolan
  • Italy · Alacare
  • Liechtenstein · Ameluz, Gliolan
  • Netherlands · Alacare
  • Norway · Alacare, Ameluz
  • Poland · Alacare
  • Portugal · Alacare
  • Sweden · Alacare
  • Slovakia · Alacare

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/137402a2-6543-466a-b3ec-716bfb79944e
GET /v1/drugs/137402a2-6543-466a-b3ec-716bfb79944e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "aminolaevulinatis hydrochloridum 8 mg",
  "valid_from": "2014-02-01",
  "limitations": "[{\"description\":\"Werden nur einzelne Pflaster aus einer Originalpackung (OP) abgegeben, so ist der Preis der verabreichten Menge proportional dem Publikumspreis der verwendeten Packung zu verrechnen.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2020-12-01\",\"validTo\":null}]",
  "galenic_form": "Pfl 8 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2014-02-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about aminolevulinic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console